Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.
Aptamers as Promising Molecular Recognition Elements for Diagnostics and Therapeutics in the Central Nervous System.
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis.
Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model.
Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
Generalised cognitive motor interference in multiple sclerosis.
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Factors influencing the desire to provide MS patient care in clinical practice among physiatrists.
Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review.
Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta-analysis.
Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro.
MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination.
HINT1 peptide/Hsp70 complex induces NK cell-dependent immunoregulation in a model of autoimmune demyelination.
Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.
How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.
The Development of Prophylactic and Therapeutic EBV Vaccines.
[Blood and cerebrospinal fluid test in multiple sclerosis].
The Impact of Increasing Multiple Sclerosis (Ms) Severity Level on Employment and Caregiver Burden.
1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Proteome analysis of post-transplantation recovery mechanisms of an EAE model of multiple sclerosis treated with embryonic stem cell-derived neural precursors.
Pediatric Inflammatory Diseases. Part II: Acute Post-Infectious Immune Disorders.
Teriflunomide for the treatment of multiple sclerosis.
Pages
« first
‹ previous
…
545
546
547
548
549
550
551
552
553
…
next ›
last »